Replimune Group, Inc. (REPL)
12.87
-0.09
(-0.69%)
USD |
NASDAQ |
Sep 17, 16:00
12.87
0.00 (0.00%)
After-Hours: 16:50
Replimune Group Total Return Level : 12.96 for Sept. 16, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 16, 2026 | 12.96 |
| September 15, 2026 | 13.03 |
| September 14, 2026 | 13.11 |
| September 11, 2026 | 12.92 |
| September 10, 2026 | 13.24 |
| September 09, 2026 | 14.45 |
| September 08, 2026 | 14.77 |
| September 04, 2026 | 15.04 |
| September 03, 2026 | 15.29 |
| September 02, 2026 | 15.98 |
| September 01, 2026 | 15.67 |
| August 31, 2026 | 15.30 |
| August 28, 2026 | 15.50 |
| August 27, 2026 | 15.60 |
| August 26, 2026 | 15.88 |
| August 25, 2026 | 15.80 |
| August 24, 2026 | 14.71 |
| August 21, 2026 | 14.77 |
| August 20, 2026 | 14.05 |
| August 19, 2026 | 14.81 |
| August 18, 2026 | 15.58 |
| August 17, 2026 | 14.63 |
| August 14, 2026 | 14.97 |
| August 13, 2026 | 15.19 |
| August 12, 2026 | 15.24 |
| Date | Value |
|---|---|
| August 11, 2026 | 13.65 |
| August 10, 2026 | 13.67 |
| August 07, 2026 | 12.06 |
| August 06, 2026 | 12.86 |
| August 05, 2026 | 11.83 |
| August 04, 2026 | 11.92 |
| August 03, 2026 | 11.91 |
| July 31, 2026 | 11.20 |
| July 30, 2026 | 5.41 |
| July 29, 2026 | 5.41 |
| July 28, 2026 | 5.35 |
| July 27, 2026 | 8.63 |
| July 24, 2026 | 9.70 |
| July 23, 2026 | 10.46 |
| July 22, 2026 | 10.75 |
| July 21, 2026 | 11.00 |
| July 20, 2026 | 10.51 |
| July 17, 2026 | 10.23 |
| July 16, 2026 | 9.52 |
| July 15, 2026 | 9.68 |
| July 14, 2026 | 9.87 |
| July 13, 2026 | 9.935 |
| July 10, 2026 | 10.99 |
| July 09, 2026 | 11.11 |
| July 08, 2026 | 11.12 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Moderna, Inc. | 145.62 |
| Kalaris Therapeutics, Inc. | 3.18 |
| Arrowhead Pharmaceuticals, Inc. | 65.79 |
| Oncolytics Biotech, Inc. | 0.7688 |
| Sangamo Therapeutics, Inc. | 0.1476 |